Home › NDC Lookup › Ingredients › Hyaluronate Sodium › 87765-0001-01
CELISTAR MICRONEEDLING INFUSION HYALURONATE SODIUM 3.5 g/100mL; 2.5 g/100mL; 2000 MW) Liquid, 20 mL — NDC 87765-0001-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CELISTAR MICRONEEDLING INFUSION HYALURONATE SODIUM 3.5 g/100mL; 2.5 g/100mL; 2000 MW) Liquid, 20 mL — NDC 87765-001-01 (Billing 87765-0001-01)

by Guangdong Outeli Biotechnology Co., Ltd. · 20 mL in 1 BOX

This is a package of 20 mL of CELISTAR MICRONEEDLING INFUSION HYALURONATE SODIUM 3.5 g/100mL; 2.5 g/100mL; 2000 MW) Liquid from Guangdong Outeli Biotechnology Co., Ltd., marketed since Jun 2026 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 87765-0001-01
🏷️ FDA NDC (as labeled) 87765-001-01 billing pads the product segment with a zero
This package
Contains20 mL Pack sizes2 compare ↓
Main listing for product 87765-001 · Also comes in: 10 ml 87765-001-02
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87765-001-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
87765 labeler · 001 product · 01 package
Package marketed since
Jun 10, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8776500101 6
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87765-001-01
Product NDC 87765-001
11-digit billing NDC 87765000101
UNII YSE9PPT4TH
Application # M016
SPL Set ID 53de46a7-3947-70a7-e063-6294a90ab829
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-06-10
Route TOPICAL
Dosage form LIQUID
Substance HYALURONATE SODIUM; HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW)
Why two NDCs? The FDA registers this code as 87765-001-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87765-0001-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Celistar Microneedling Infusion is a topical liquid containing hyaluronate sodium and hydrolyzed marine collagen. These ingredients are commonly used in skincare products designed to support skin hydration and moisture retention. The product is formulated as an over-the-counter monograph drug intended for application to the skin, typically in connection with microneedling procedures or other topical skincare routines. Hyaluronate sodium and collagen are typical components in products aimed at skin conditioning and appearance.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 10 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87765-0001-01 You're viewing this Main listing 20 mL in 1 BOX 2026-06-10 — Active
87765-0001-02 87765-001-02 10 mL in 1 BOX 2026-06-10 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 20 mL — 20 ml in 1 box.
How does this package differ from NDC 87765-0001-02?
Both are CELISTAR MICRONEEDLING INFUSION HYALURONATE SODIUM 3.5 g/100mL; 2.5 g/100mL; 2000 MW) Liquid — the drug itself is identical. This page's package is the 20 mL one, while NDC 87765-0001-02 is the 10 ml package.
What NDC number is used to bill for this package of CELISTAR MICRONEEDLING INFUSION HYALURONATE SODIUM 3.5 g/100mL; 2.5 g/100mL; 2000 MW) Liquid?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Celistar Microneedling Infusion 3.5 g/100mL; 2.5 g/100mL; 2000 MW)this 87765-0001-01 Guangdong 20 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jun 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 86.31 g / 100 mL UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesAQUA 86.31% ERGOTHIONEINE 0.12% ACETYL HEXAPEPTIDE-8 AMIDE 0.08% ACETYL TETRAPEPTIDE-11 0.06% ACETYL TETRAPEPTIDE-9 0.04% PALMITOYL TRIPEPTIDE-1 0.04% PALMITOYL TETRAPEPTIDE-7 0.04% GLYCERIN 3.5% BUTYLENE GLYCOL 2.8% 1,2-HEXANEDIOL 0.3% HYDROXYACETOPHENONE 0.2% MANNITOL 0.15% CARBOMER HOMOPOLYMER TYPE B 0.1% L-ARGININE 0.12% SODIUM LACTATE, L- 0.18%

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGuangdong Outeli Biotechnology Co., Ltd.
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code87765
First marketedJun 2026
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Guangdong Outeli Biotechnology Co., Ltd. labeler code 87765

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

Uses: Antioxidant and skin protectant,Anti aging and wrinkle reducer, Skin moisturizer and conditioner

⏱️ Dosage and Administration 116 words ▾

Serum 5ml x 4+Mincroneedle Stamp x 4 HOW TO USE: For best results, use every 2 weeks.Treatment time: 10-15 minutes. 1. Start with clean hands.

Remove the sterile applicator from the packaging.Do not use if the sterile seal is broken. 2. Cleanse your face thoroughly with warm water and pat dry.

3. Prepare the device: Open the 5ml ampoule serum. Carefully fill the applicator's reservoir with the essence.

Se- curely screw the top back on and gently shake 2-3 times to mix. 4. Remove the protective safety cover immediately before use.

5.Application technique: Begin at the center of your face, gently stamping outward.For optimal absorption, use a 50% overlapping pattern and repeat 2-3 times per area.

⚠️ Warnings 29 words ▾

Do not use on broken, irritated, or sensitive skin. Avoid contact with eyes. lf contact occurs,rinse immediately with plenty of water. Discontinue use immediately if discomfort or irritation occurs.

🧪 Active Ingredient 9 words ▾

HYALURONATE SODIUM 3.5% HYDROLYSED MARINE COLLAGEN(ENZYMATIC; 2000 MW) 2.5%

🧪 Inactive Ingredients 42 words ▾

AQUA 86.31% ERGOTHIONEINE 0.12% ACETYL HEXAPEPTIDE-8 AMIDE 0.08% ACETYL TETRAPEPTIDE-11 0.06% ACETYL TETRAPEPTIDE-9 0.04% PALMITOYL TRIPEPTIDE-1 0.04% PALMITOYL TETRAPEPTIDE-7 0.04% GLYCERIN 3.5% BUTYLENE GLYCOL 2.8% 1,2-HEXANEDIOL 0.3% HYDROXYACETOPHENONE 0.2% MANNITOL 0.15% CARBOMER HOMOPOLYMER TYPE B 0.1% L-ARGININE 0.12% SODIUM LACTATE, L- 0.18%

🎯 Purpose 19 words ▾

Anti-aging Makes skin feel firmer, enhances appearance for 'a plumper,visibly improves appearance of fine lines,evens skin tone, and smoother.

📄 Keep Out of Reach of Children 28 words ▾

Keep the applicator out of reach of children. Avoid contact with eyes.lf contact occurs, rinse immediately with plenty of water. Discontinue use immediately if discomfort or irritation occurs.

📄 Package Label / Principal Display Panel 4 words ▾

Label image Label image

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for HYALURONATE SODIUM — the ingredient across all brands.

Top reported reactions

Headache195
Hypertension149
Dyspnoea137
Asthma132
Hypothyroidism132
Gastrooesophageal Reflux Disease129
Burning Sensation125

Age at onset

Infant2
Child3
Adolescent4
Adult163
Elderly222

Reporter sex

1,493 reports
Male · 33%
Female · 67%
Unknown · 0%

Serious outcomes

Hospitalization717
Death113
Disabling72
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 300 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Guangdong Outeli Biotechnology Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 10 ml (87765-0001-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Guangdong Outeli Biotechnology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87762-0001-01 · Shenzhen 87765-0002-01 · Guangdong →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.